As a digital replica of a physical asset or process, a digital twin simulates its real-world counterpart. This concept, aligned with broader trends such as Industry 4.0, is now accelerating drug development, optimising production and enhancing patient outcomes.
Here, Stephan Nobis, Business Development Manager at automation supplier COPA-DATA, explores how digital twin technology can optimise pharmaceutical manufacturing operations.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.